Double Case Control Study on Effect of Ibuprofen and Acetaminophen in Premature Neonate with Patent Ductus Arteriosus in Neonatal Intensive Care Unit in Sulaimania Maternity Hospital

Vian Omar  Mussa; Aso Faeq  Salih

doi:10.56056/amj.2018.53

Authors

Vian Omar Mussa M.B.Ch.B. Department of Pediatrics. Sulaimania Training Center
Aso Faeq Salih Assistant professor of Pediatrics College of Medicine University of Sulaimania Corresponding author: Vian Omar Mussa

DOI:

https://doi.org/10.56056/amj.2018.53

Keywords:

Patent ductus arteriosus, Ibuprofen, Acetaminophen, Premature neonates

Abstract

Backgrounds and objectives:Persistent patency of the ductus arteriosus is a major cause of morbidity and mortality in premature infants. Cyclooxygenase inhibitors remain the mainstay of medical therapy for patent ductus arteriosus. The aim of this study is to evaluate pharmacological closures of Patent Ductus Artriosus in premature babies. Patients and

Methods:Double case control study done on sixty premature neonates with a gestational age (25-37) weeks, who were admitted to the Sulaimania maternity hospital from February to September 2017. Patent ductus artriosus diagnosis was confirmed by echocardiography. Twenty neonates received oral ibuprofen, an initial dose of 20mg/kg, followed by 10mg/kg at 24 or 48 hours later, twenty cases received oral acetaminophen in dose of 20mg/kg as initial dose, followed by 15mg/kg every eight hours for 3 days. Twenty cases not received treatment after taking consent from their family. The second echo was done after completed treatment.

Results: In sixty premature neonates with patent ductus arteriosus; twenty cases received ibuprofen 14 cases responded to the treatment (70%), and 7 cases (35%) developed side effects, twenty cases received acetaminophen 11 cases responded to the treatment (55%), and side effects developed in just 3 cases (15%). lastly twenty cases received no treatment patent ducts arteriosus closed in just 8 cases (40%).

Conclusions: Ibuprofen is slightly more effective on the closing of the PDA in preterm infants than acetaminophen, but the latter has fewer side effects and using medication is preferred on using no medication

Downloads

Download data is not yet available.

References

Hamrick S, Hansmann G. Patent Ductus Arteriosus of the Preterm Infant. Pediatrics. 2010; 125(5):1020–30. Available from: http:// pediatrics.aappublications.org/cgi/doi/10.1542/peds.2009-3506

Yokoyama U, Minamisawa S, Ishikawa Y. Regulation of vascular tone and remodeling of the ductus arteriosus. J Smooth Muscle Res.2010;46(2):77–87. Available from: http://joi.jlc.jst.go.jp/JST.JSTAGE/jsmr/46.77from=CrossRef.

Lemons J, Bauer C, Oh W et al. Very Low Birth Weight Outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 Through December 1996. Pediatrics. 2001 ;107(1):e1–e1. Available from: http://pediatrics.aappublications. org/cgi/doi/10.1542/peds.107.1.e1.

Koch J. Prevalence of Spontaneous Closure of the Ductus Arteriosus in Neonates at a Birth Weight of 1000 Grams or Less. Pediatrics. 2006:;117(4):1113–21. Available from: http://pediatrics.aappublications.org/ cgi/doi/10.1542/peds.2005-1528.

R5. Richards J, Johnson A, Fox G, Campbell M. A Second Course of Ibuprofen Is Effective in the Closure of a Clinically Significant PDA in ELBW Infants. Pediatrics. 2009 ;124(2):e287–93. Available from: http:// pediatrics.aappublications.org/cgi/doi/10.1542/peds.2008-2232

Did K, J I, L W-F et al. Patent Ductus Arteriosus. Critical Care of Children with Heart Disease. 2010. p. 145–57.

Mouzinho A, Rosenfeld C, Risser R. Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987-1989. Early Hum Dev.1991;27(1–2):65–77. [cited 2018 Mar 2]. Available from: http://www. ncbi.nlm.nih.gov/pubmed/180266.

Fanos V, Pusceddu M, Dessì A, Marcialis M. A should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new- burns? Clinics. 2011; 66(12):2141– 2149. doi: 10.1590/S1807- 59322011001200022.

Antonucci R, Bassareo P, Zaffanello M, Pusceddu M, Fanos V. Patent ductus arteriosus in the preterm infant: new insights into pathogenesis and clinical management. J Matern Neonatal Med. 2010 ;23(sup3):34–7. Available from: ttp://www.tandfonline.com/doi/full/10.3109/14767 058.2010.509920

Alfaleh K, Smyth J, Roberts R, Solimano A, Asztalos E, Schmidt B. Prevention and 18-Month Outcomes of Serious Pulmonary Hemorrhage in Extremely Low Birth Weight Infants: Results From the Trial of Indomethacin Prophylaxis in Preterms. Pediatrics. 2008;121(2):e233–8. Available from: http://pediatrics.aappublications.org/ cgi/doi/10.1542/peds.2007-0028.

Vettukattil J. Editorial (Thematic Issue: Patent Ductus Arteriosus in Extremely Premature Neonates). Curr Pediatr Rev. 2016 ;12(2):78–82. Available from: http://www.eurekaselect. com/openurl/content.php?genre=article&issn=1573- 3963&volume=12&issue=2&spage=78.

Abdel-Hady H, Nasef N, Shabaan AE, Nour I. Patent Ductus Arteriosus in Preterm Infants: Do We Have the Right Answers? Biomed Res Int. 2013;2013:1–15. Available from: http://www.hindawi.com/ journals/bmri/2013/676192/.

Terrin G, Conte F, Oncel MY, Scipione A, McNamara PJ, Simons S, et al. Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis. Arch Dis Child - Fetal Neonatal Ed. 2016 ;101(2):F127–36. Available from: http://fn.bmj.com/ lookup/doi/10.1136/archdischild-2014-307312.

Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal Closure With Paracetamol: A Surprising New Approach to Patent Ductus Arteriosus Treatment. Pediatrics. 2011 ;128(6):e1618–21. Available from: http://pediatrics.aappublications. org/cgi/doi/10.1542/peds.2011-0359.

Wald R, Adatia I, Van Arsdell G et al. Relation of limiting ductal patency to survival in neonatal Epstein’s anomaly. Am J Cardiol. 2005; 96(6):851–6.

Habibi M, Nobakht M, Pirbazari T, Yazdi Z. The Effect of Oral Ibuprofen and Oral Acetaminophen in the Patent Ductus Arteriosus (pda) in Preterm Infants Born in Kouvsar Hospital of Qazvin (a Comparative Study). WORLD J Pharm Med Res. 2016;2(4):203–7.

Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled Trial. Choonara I, editor. PLoS One. 2013;8(11):e77888. [cited 2018 Mar 2]. Available from: http://dx.plos.org/10.1371/journal.pone.0077888.

Ghanem S, Mostafa M, Shafee M. Effect of oral ibuprofen on patent ductus arteriosus in premature newborns. J Saudi Hear Assoc. 2010 ;22(1):7–12. Available from: http://linkinghub.elsevier.com/retrieve/pii/ S1016731510001247.

Yang B, Gao X, Ren Y, Wang Y, Zhang Q. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial. Exp Ther Med. 2016 ;12(4):2531–6. Available from: https://www.spandidos publications. com/10.3892/etm.2016.3676.